Oxford–AstraZeneca COVID-19 vaccine efficacy
Open Access
- 8 December 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 397 (10269), 72-74
- https://doi.org/10.1016/s0140-6736(20)32623-4
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Merck
This publication has 3 references indexed in Scilit:
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2020
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialThe Lancet, 2020
- A global agenda for older adult immunization in the COVID-19 era: A roadmap for actionVaccine, 2020